Literature DB >> 24113258

Non-neuronal cell responses differ between normal and Down syndrome developing brains.

Takeshi Kanaumi1, Ivan Milenkovic, Homa Adle-Biassette, Eleonora Aronica, Gabor G Kovacs.   

Abstract

Down syndrome (DS), the most common genetic cause of mental retardation, is characterized by reduced number of neurons and delayed myelination. Though non-neuronal cells in the brain are vital for the development, survival, and function of neurons, there is a paucity of comparative studies of normal development and DS, in particular in the temporal lobe, a region of interest for cognitive decline. We evaluated immunoreactivity for CD68 (macrophage), HLA-DR (microglia), Olig2 and TPPP/p25 (oligodendroglia), and GFAP (astroglia) in the germinal matrix (GM), temporal lobe white matter (TeWM) and hippocampus from 14 weeks of gestations to newborn in 28 DS patients and 30 age-matched controls. The rate of increase of CD68 positive cells in the GM, CA1 hippocampal subregion and subiculum was significantly higher in DS. The density of Olig2 positive cells in the GM was lower in DS brains at early stages, then showed a transient increase contrasting controls. Olig2 expression increased more in the TeWM in DS, suggesting an altered pattern of oligodendrocyte progenitor generation. GFAP-immunoreactivity in DS was significantly lower in the middle pregnancy period in the TeWM and did not increase between early and middle periods in the GM compared to controls, likely reflecting a defect in astrocyte production. The altered expression of non-neuronal cell markers during normal development and DS may play a role in, or reflect, defective neurogenesis, leading to reduced number of neurons and delayed myelination in the developing DS brain. This has implications for the understanding of the mental retardation in DS patients.
Copyright © 2013 ISDN. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD68; Fetus; GFAP; HLA-DR; Human; Olig2; TPPP/p25

Mesh:

Substances:

Year:  2013        PMID: 24113258     DOI: 10.1016/j.ijdevneu.2013.09.011

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  15 in total

1.  Quantitative MRI Analyses of Regional Brain Growth in Living Fetuses with Down Syndrome.

Authors:  Tomo Tarui; Kiho Im; Neel Madan; Rajeevi Madankumar; Brian G Skotko; Allie Schwartz; Christianne Sharr; Steven J Ralston; Rie Kitano; Shizuko Akiyama; Hyuk Jin Yun; Ellen Grant; Diana W Bianchi
Journal:  Cereb Cortex       Date:  2020-01-10       Impact factor: 5.357

2.  The innate immune system stimulating cytokine GM-CSF improves learning/memory and interneuron and astrocyte brain pathology in Dp16 Down syndrome mice and improves learning/memory in wild-type mice.

Authors:  Md Mahiuddin Ahmed; Athena Ching-Jung Wang; Mihret Elos; Heidi J Chial; Stefan Sillau; D Adriana Solano; Christina Coughlan; Leila Aghili; Paige Anton; Neil Markham; Vanesa Adame; Katheleen J Gardiner; Timothy D Boyd; Huntington Potter
Journal:  Neurobiol Dis       Date:  2022-03-18       Impact factor: 7.046

3.  Regional Alterations in Cortical Sulcal Depth in Living Fetuses with Down Syndrome.

Authors:  Hyuk Jin Yun; Juan David Ruiz Perez; Patricia Sosa; J Alejandro Valdés; Neel Madan; Rie Kitano; Shizuko Akiyama; Brian G Skotko; Henry A Feldman; Diana W Bianchi; P Ellen Grant; Tomo Tarui; Kiho Im
Journal:  Cereb Cortex       Date:  2021-01-05       Impact factor: 5.357

4.  High resolution structural and functional MRI of the hippocampus in young adults with Down syndrome.

Authors:  Katherine A Koenig; Se-Hong Oh; Melissa R Stasko; Elizabeth C Roth; H Gerry Taylor; Stephen Ruedrich; Z Irene Wang; James B Leverenz; Alberto C S Costa
Journal:  Brain Commun       Date:  2021-04-19

Review 5.  Human astrocytes in the diseased brain.

Authors:  Elena Dossi; Flora Vasile; Nathalie Rouach
Journal:  Brain Res Bull       Date:  2017-02-13       Impact factor: 4.077

6.  GABAA receptor subunit deregulation in the hippocampus of human foetuses with Down syndrome.

Authors:  Ivan Milenkovic; Tamara Stojanovic; Eleonora Aronica; Livia Fülöp; Zsolt Bozsó; Zoltán Máté; Yuchio Yanagawa; Homa Adle-Biassette; Gert Lubec; Gábor Szabó; Tibor Harkany; Gábor G Kovács; Erik Keimpema
Journal:  Brain Struct Funct       Date:  2017-11-22       Impact factor: 3.270

Review 7.  New approaches to studying early brain development in Down syndrome.

Authors:  Ana A Baburamani; Prachi A Patkee; Tomoki Arichi; Mary A Rutherford
Journal:  Dev Med Child Neurol       Date:  2019-05-17       Impact factor: 5.449

Review 8.  Aberrant Oligodendrogenesis in Down Syndrome: Shift in Gliogenesis?

Authors:  Laura Reiche; Patrick Küry; Peter Göttle
Journal:  Cells       Date:  2019-12-07       Impact factor: 6.600

9.  Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling.

Authors:  Alán Alpár; Giuseppe Tortoriello; Daniela Calvigioni; Micah J Niphakis; Ivan Milenkovic; Joanne Bakker; Gary A Cameron; János Hanics; Claudia V Morris; János Fuzik; Gabor G Kovacs; Benjamin F Cravatt; John G Parnavelas; William D Andrews; Yasmin L Hurd; Erik Keimpema; Tibor Harkany
Journal:  Nat Commun       Date:  2014-07-17       Impact factor: 14.919

10.  Opportunities, barriers, and recommendations in down syndrome research.

Authors:  James A Hendrix; Angelika Amon; Leonard Abbeduto; Stamatis Agiovlasitis; Tarek Alsaied; Heather A Anderson; Lisa J Bain; Nicole Baumer; Anita Bhattacharyya; Dusan Bogunovic; Kelly N Botteron; George Capone; Priya Chandan; Isabelle Chase; Brian Chicoine; Cécile Cieuta-Walti; Lara R DeRuisseau; Sophie Durand; Anna Esbensen; Juan Fortea; Sandra Giménez; Ann-Charlotte Granholm; Laura J Hahn; Elizabeth Head; Hampus Hillerstrom; Lisa M Jacola; Matthew P Janicki; Joan M Jasien; Angela R Kamer; Raymond D Kent; Bernard Khor; Jeanne B Lawrence; Catherine Lemonnier; Amy Feldman Lewanda; William Mobley; Paul E Moore; Linda Pollak Nelson; Nicolas M Oreskovic; Ricardo S Osorio; David Patterson; Sonja A Rasmussen; Roger H Reeves; Nancy Roizen; Stephanie Santoro; Stephanie L Sherman; Nasreen Talib; Ignacio E Tapia; Kyle M Walsh; Steven F Warren; A Nicole White; Guang William Wong; John S Yi
Journal:  Transl Sci Rare Dis       Date:  2021-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.